Primum non nocere

This article has been updated

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1: Blood pressure targets in European and American Guidelines.

Change history

  • 03 July 2020

    The original HTML/PDF versions of this Article were updated in order to complete the details in references 1 and 2.

References

  1. 1.

    Ruilope LMR-H G. Management of hypertension in the very old: aggressive reduction of blood pressure is harmful in most patients. J Hum Hypertens. 2020. https://doi.org/10.1038/s41371-020-0346-0.

  2. 2.

    Angeli FR G, Verdecchia P. Management of hypertension in the very old: an aggressive reduction of blood pressure should be achieved in most patients. J Hum Hypertens. 2020. https://doi.org/10.1038/s41371-020-0345-1.

  3. 3.

    Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–104.

    Article  Google Scholar 

  4. 4.

    Whelton PK, Carey RM, Aronow WS, Casey DE, Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:1269–324.

    CAS  Article  Google Scholar 

  5. 5.

    Group SR, Wright JT Jr., Williamson JD, Whelton PK, Snyder JK, Sink KM, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103–16.

    Article  Google Scholar 

  6. 6.

    Williamson JD, Supiano MA, Applegate WB, Berlowitz DR, Campbell RC, Chertow GM, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged >/=75 years: a randomized clinical trial. JAMA. 2016;315:2673–82.

    CAS  Article  Google Scholar 

  7. 7.

    Amrhein V, Greenland S, McShane B. Scientists rise up against statistical significance. Nature. 2019;567:305–7.

    CAS  Article  Google Scholar 

  8. 8.

    Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887–98.

    CAS  Article  Google Scholar 

  9. 9.

    Vidal-Petiot E, Greenlaw N, Ford I, Ferrari R, Fox KM, Tardif JC, et al. Relationships between components of blood pressure and cardiovascular events in patients with stable coronary artery disease and hypertension. Hypertension. 2018;71:168–76.

    CAS  Article  Google Scholar 

  10. 10.

    Esposito R, Izzo R, Galderisi M, DM M, Stabile E, Esposito G, et al. Identification of phenotypes at risk of transition from diastolic hypertension to isolated systolic hypertension. J Hum Hypertens. 2016;30:392–6.

    CAS  Article  Google Scholar 

  11. 11.

    Bohm M, Schumacher H, Teo KK, Lonn E, Mahfoud F, Mann JFE, et al. Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-40 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. Eur Heart J. 2018;39:3105–14.

    CAS  Article  Google Scholar 

  12. 12.

    Izzo R, Mancusi C, De Stefano G, Albano G, Losi MA, Trimarco V, et al. Achievement of target SBP without attention to decrease in DBP can increase cardiovascular morbidity in treated arterial hypertension: the Campania Salute Network. J Hypertens. 2019;37:1889–97.

    CAS  Article  Google Scholar 

  13. 13.

    Anderson TS, Jing B, Auerbach A, Wray CM, Lee S, Boscardin WJ, et al. Clinical outcomes after intensifying antihypertensive medication regimens among older adults at hospital discharge. JAMA Intern Med. 2019;179:1528–36.

    Article  Google Scholar 

  14. 14.

    Levine DA, Galecki AT, Langa KM, Unverzagt FW, Kabeto MU, Giordani B, et al. Blood pressure and cognitive decline over 8 years in middle-aged and older Black and White Americans. Hypertension. 2019;73:310–8.

    CAS  Article  Google Scholar 

  15. 15.

    Group SMIftSR, Williamson JD, Pajewski NM, Auchus AP, Bryan RN, Chelune G, et al. Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial. JAMA. 2019;321:553–61.

    Article  Google Scholar 

  16. 16.

    Iadecola C, Yaffe K, Biller J, Bratzke LC, Faraci FM, Gorelick PB, et al. Impact of hypertension on cognitive function: a scientific statement from the American Heart Association. Hypertension. 2016;68:e67–e94.

    CAS  Article  Google Scholar 

  17. 17.

    Sabayan B, Oleksik AM, Maier AB, van Buchem MA, Poortvliet RK, de Ruijter W, et al. High blood pressure and resilience to physical and cognitive decline in the oldest old: the Leiden 85-plus Study. J Am Geriatr Soc. 2012;60:2014–9.

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Giovanni de Simone.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

de Simone, G., Mancusi, C. Primum non nocere. J Hum Hypertens 34, 547–550 (2020). https://doi.org/10.1038/s41371-020-0366-9

Download citation

Search